The carboxy-terminal cell-binding domain of thrombospondin is essential for sickle red blood cell adhesion

Blood

Volumn 94, Issue 1, 1999, Pages 302-309

  Hillery, Cheryl A ^a   Scott, J Paul ^b   Du, Ming C ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARBOXY TERMINAL SEQUENCE; ERYTHROCYTE ADHESIVENESS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMOBILIZATION; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0033168348     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.302.413k38_302_309     Document Type: Article

References (39)

1. Hillery CA: Potential therapeutic approaches for the treatment of vaso-occlusion in sickle cell disease. Curr Opin Hematol 5:151, 1998
2. Hebbel RP: Beyond hemoglobin polymerization: The red blood cell membrane and sickle disease pathophysiology. Blood 77:214, 1991
3. Bunn HF: Pathogenesis and treatment of sickle cell disease. N Engl J Med 337:762, 1997
4. Hebbel RP, Morgan WT, Eaton JW, Hedlund BE: Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA 85:237, 1988
5. Brugnara C, Bunn HF, Tosteson DC: Regulation of erythrocyte cation and water content in sickle cell anemia. Science 232:388, 1986
6. Waugh SM, Willardson BM, Kannan R, Labotka RJ, Low PS: Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J Clin Invest 78:1155, 1986
7. Franck PFH, Bevers EM, Lubin BH, Comfurius P, Chiu DT, Op den Kamp JA, Zwaal RFA, van Deenen LL, Roelofsen B: Uncoupling of the membrane skeleton from the lipid bilayer: The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickle cells. J Clin Invest 75:183, 1985
8. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW: Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest 65:154, 1980
9. Barabino GA, McIntire LV, Eskin SG, Sears DA, Udden M: Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 70:152, 1987
10. French JA II, Kenny D, Scott JP, Hoffmann RG, Wood JD, Hudetz AG, Hillery CA: Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition. Blood 89:4591, 1997
11. Fabry ME, Rajanayagam V, Fine E, Holland S, Gore JC, Nagel RL, Kaul DK: Modeling sickle cell vasoocclusion in the rat leg: Quantification of trapped sickle cells and correlation with 31P metabolic and 1H magnetic resonance imaging changes. Proc Natl Acad Sci USA 86:3808, 1989
12. Kaul DK, Fabry ME, Costantini F, Rubin EM, Nagel RL: In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 96:2845, 1995
13. Santoro SA, Frazier WA: Isolation and characterization of thrombospondin. Methods Enzymol 144:438, 1987
14. Slayter HS: Secretion of thrombospondin from human blood platelets. Methods Enzymol 169:251, 1989
15. Roberts DD, Rao CN, Liotta LA, Gralnick HR, Ginsburg V: Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem 261:6872, 1986
16. Dixit VM, Grant GA, Santoro SA, Frazier WA: Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem 259:10100, 1984
17. Asch AS, Silbiger S, Heimer E, Nachman RL: Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 182:1208, 1992
18. Lawler J, Weinstein R, Hynes RO: Cell attachment to thrombospondin: The role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 107:2351, 1988
19. Kosfeld MD, Frazier WA: Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin. J Biol Chem 268:8808, 1993
20. Adams JC, Lawler J: Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell 5:423, 1994
21. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
22. Ugarova T, Agbanyo FR, Plow EF: Conformational changes in adhesive proteins modulate their adhesive function. Thromb Haemost 74:253, 1995
23. Sugihara K, Sugihara T, Mohandas N, Hebbel RP: Thrombospondin mediates adherence of CD364+ sickle reticulocytes to endothelial cells. Blood 80:2634, 1992
24. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM: Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vasoocclusion. Blood 81:2137, 1993
25. Hillery CA, Du MC, Montgomery RR, Scott JP: Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 87:4879, 1996
26. Joneckis CC, Shock DD, Cunningham ML, Orringer EP, Parise LV: Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. Blood 87:4862, 1996
27. Jones DA, Abbassi O, Mclntire LV, McEver RP, Smith CW: P-Selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys J 65:1560, 1993
28. Galvin NJ, Vance PM, Dixit VM, Fink B, Frazier WA: Interaction of human thrombospondin with types I-V collagen: Direct binding and electron microscopy. J Cell Biol 104:1413, 1987
29. Prater CA, Plotkin J, Jaye D, Frazier WA: The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J Cell Biol 112:1031, 1991
30. Kosfeld MD, Pavlopoulos TV, Frazier WA: Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. J Biol Chem 266:24257, 1991
31. Dixit VM, Haverstick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA: A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci USA 82:3472, 1985
32. Galvin NJ, Dixit VM, O'Rourke KM, Santoro SA, Grant GA, Frazier WA: Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J Cell Biol 101:1434, 1985
33. Kosfeld MD, Frazier WA: Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. J Biol Chem 267:16230, 1992
34. Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV: Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263, 1993
35. Natarajan M, Udden MM, McIntire LV: Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells underflow in vitro. Blood 87:4845, 1996
36. Lawler J, Simons ER: Cooperative binding of calcium to thrombospondin. The effect of calcium on the circular dichroism and limited tryptic digestion of thrombospondin. J Biol Chem 258:12098, 1983
37. Slane JM, Mosher DF, Lai CS: Conformational change in thrombospondin induced by removal of bound Ca2+. A spin label approach. FEBS Lett 229:363, 1988
38. Speziale MV, Detwiler TC: Free thiols of platelet thrombospondin. Evidence for disulfide isomerization. J Biol Chem 265:17859, 1990
39. Barabino GA, Wise RJ, Woodbury VA, Zhang B, Bridges KA, Hebbel RP, Lawler J, Ewenstein BM: Inhibition of sickle erythrocyte adhesion to immobilized thrombospondin by von Willebrand factor under dynamic flow conditions. Blood 89:2560, 1997